ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

LEGN Legend Biotech Corporation

45.16
-0.25 (-0.55%)
최종 업데이트: 23:00:46
15분 지연
기업명 주식 심볼 시장 주식 타입
Legend Biotech Corporation LEGN 나스닥 주식예탁증서 (DR)
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.25 -0.55% 45.16 23:00:46
개장가 저가 고가 종가 전일 종가
45.41 44.7201 45.43 45.41
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
23/04/202402:05BWCARVYKTI® (ciltacabtagene autoleucel) Approved by the..
11/04/202421:00BWLegend Biotech to Host Investor Conference Call on First..
06/04/202412:30BWLegend Biotech’s CARVYKTI® (ciltacabtagene autoleucel)..
19/03/202421:30BWLegend Biotech Announces Publication of Inaugural..
16/03/202404:15BWCARVYKTI® (ciltacabtagene autoleucel) Receives..
11/03/202420:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/03/202420:00BWLegend Biotech Reports Fourth Quarter and Full Year 2023..
11/03/202419:39IHMARKETNEWSU.S. Index Futures Dip Ahead of Inflation Data and Oracle’s..
29/02/202408:46EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
28/02/202409:47EDGAR2Form 144 - Report of proposed sale of securities
24/02/202403:10EDGAR2Form 144 - Report of proposed sale of securities
23/02/202421:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/02/202421:15BWLegend Biotech Announces Positive CHMP Opinion for CARVYKTI®..
15/02/202410:34EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/02/202422:00BWLegend Biotech to Host Investor Conference Call on Fourth..
23/01/202423:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/01/202421:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/01/202406:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/01/202401:28BWLegend Biotech Announces Closing of License Transaction for..
03/01/202422:30BWLegend Biotech Announces Closing of License Transaction for..
02/01/202422:30BWLegend Biotech to Participate in the 42nd Annual J.P. Morgan..
28/12/202300:00EDGAR2Form 144 - Report of proposed sale of securities
23/12/202305:38EDGAR2Form 144 - Report of proposed sale of securities
23/12/202305:21EDGAR2Form 144 - Report of proposed sale of securities
22/12/202307:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/12/202306:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/12/202304:31EDGAR2Form 144 - Report of proposed sale of securities
12/12/202309:30BWPatient-Reported Outcomes from the CARTITUDE-4 Study Showed..
20/11/202320:25IHMARKETNEWSMonday’s Wall Street Highlights: GM, Microsoft, Citigroup,..
20/11/202320:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/11/202320:00BWLegend Biotech Reports Third Quarter 2023 Results and Recent..
13/11/202323:16DJNLegend Biotech Subsidiary in License Agreement With Novartis
13/11/202322:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/11/202322:30BWLegend Biotech Announces Exclusive, Global License Agreement..
07/11/202322:30BWLegend Biotech to Host Investor Conference Call on..
02/11/202322:17BWLegend Biotech to Showcase Leadership in Multiple Myeloma..
18/10/202306:39EDGAR2Form 144 - Report of proposed sale of securities
17/10/202321:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/10/202306:20EDGAR2Form 144 - Report of proposed sale of securities
28/09/202301:02EDGAR2Form 144 - Report of proposed sale of securities
25/09/202321:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/09/202305:20EDGAR2Form 144 - Report of proposed sale of securities
23/09/202305:10EDGAR2Form 144 - Report of proposed sale of securities
19/09/202305:41EDGAR2Form 144 - Report of proposed sale of securities
28/08/202323:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/08/202305:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/08/202319:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/08/202319:00BWLegend Biotech Reports Second Quarter 2023 Results and..
03/08/202321:30BWLegend Biotech to Host Investor Conference Call on..
20/07/202321:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

최근 히스토리

Delayed Upgrade Clock